Navigation Links
Woods Hole Research Center plans controlled burn in Amazon rainforest

fires under a forest canopy. According to Nepstad, "One of the discoveries from our first year of burning is that forest understory fires are invisible to the coarse-resolution satellites that are used to monitor active fires around the world. The fire and subsequent fire scar could both be easily seen, however, using the Hyperion EO-1 sensor data. Our hope is that these studies will allow us to better monitor forest fire from space and, eventually, to determine which forests are most susceptible to fire during the dry season."

The "savannization experiment" is a learning laboratory for Brazilian students who live in the Amazon transition forest. School groups frequently visit the research station, and eight college students are conducting their undergraduate theses within the project. The Grupo Maggi, the world's largest private producer of soybeans, owns the study site. By conducting this work on this property, it is hoped that the fire experiment, along with concurrent studies of riparian zone recuperation, soil management, and water quality, will help this and other companies improve the ecological management of their properties. Grupo Maggi provides no funding for this research.


'"/>

Source:Woods Hole Research Center


Page: 1 2 3 4 5

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
3. Researchers find how protein allows insects to detect and respond to pheromones
4. Researchers Uncover Key Step In Manufacture of Memory Protein
5. Research advances quest for HIV-1 vaccine
6. Research on Worms Yields Clues on Aging
7. Researchers reveal the infectious impact of salmon farms on wild salmon
8. Researchers identify target for cancer drugs
9. Weill Cornell Research Reveals Secrets Of Trafficking Within Cells
10. Researchers discover molecule that causes secondary stroke
11. Researchers find missing genes of ancient organism
Post Your Comments:
(Date:12/16/2009)... of Maryland School of Medicine researcher will lead the ... prominent scientists in the field of stem cell research. ... Medicine, was chosen by the National Heart, Lung and ... consortium of national experts, which will be called the ... be funded by a $30 million grant over seven ...
(Date:12/16/2009)... Dec. 2 DigitalPersona, Inc., a ... today announced an agreement with IBM to ... biometric fingerprint technology on IBM SurePOS 500 ... allows point-of-sale applications to more easily and ... can be linked to the individuals who ...
(Date:12/16/2009)... -- IgeaCare Solutions Inc. is pleased to announce ... communications company previously operating as IgeaCare Systems Inc. ... forward under new leadership and funding. ,, IgeaCare ... the position of Chief Executive Officer. Under his ... a superior servicing and support model; fast and ...
Breaking Biology News(10 mins):University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2Food Security to be the Top Issue for EUs Science Chief 62345 1Food Security to be the Top Issue for EUs Science Chief 62345 2Palatin Technologies Inc Issued U S Patent for Heart Failure Drug Candidate 15020 1Palatin Technologies Inc Issued U S Patent for Heart Failure Drug Candidate 15020 2Palatin Technologies Inc Issued U S Patent for Heart Failure Drug Candidate 15020 3Medicare Administrator Establishes Reimbursement Coding Policy for Agendias Breast Cancer Recurrence Test MammaPrint 28R 29 15018 1Medicare Administrator Establishes Reimbursement Coding Policy for Agendias Breast Cancer Recurrence Test MammaPrint 28R 29 15018 2
... drug warfarin to prevent harmful clotting after a heart attack, ... can vary greatly and can be hard to predict. Some ... gene involved in blood clotting, according to a new study ... Journal of Medicine. , By looking at the genetic makeup ...
... function of the microRNA mir1, Drs. Nicholas Sokol ... the expression profile, transcriptional regulation and loss-of-function phenotype ... conserved miRNA, whose expression in mouse and humans ... Strikingly, their study shows that, in Drosophila embryos, ...
... at the University of North Carolina Hospitals arrived in ... glowing track record in helping to repair heart valves, ... gastric bypass operations for morbid obesity. , The new ... System, manufactured by Intuitive Surgical. UNC currently is the ...
Other Biology News:Genetic variation alters response to common anti-clotting drug 2Genetic variation alters response to common anti-clotting drug 3Screen all at risk for HIV, plus pregnant women 2Screen all at risk for HIV, plus pregnant women 3
(Date:12/15/2009)... -- Thomson Reuters today ... the first drug pipeline database to fully integrate ... highly anticipated new content is being provided to ... ,, Thomson Pharma will offer drug ... releases, conferences, and other sources across all therapeutic ...
(Date:12/14/2009)... Vermillion, Inc. (Pink Sheets: VRML), ... C. Wallen, Ph.D. Chief Scientific Officer, Senior ... Laboratories, will be joining its board of ... ,, "Bill brings more than 20 ... and biotechnology," said Gail Page, Vermillion Executive ...
(Date:12/14/2009)... Dec. 14 Boston Scientific Corporation (NYSE: ... public offering of $2 billion aggregate principal amount of ... The public offering consists of $850 million of ... 6.00 percent notes due January 2020 and $300 million ... Scientific plans to use the net proceeds for general ...
(Date:12/14/2009)... delivery of Brookfield Engineering’s Powder Flow Tester – helping Brookfield ... smaller footprint and more compact design. , ... ... a US-based thermoforming company, has completed the delivery of Brookfield ... metal to a plastic enclosure with a smaller footprint and ...
Breaking Biology Technology:Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2
... Maxygen, Inc.,(Nasdaq: MAXY ), a biotechnology company ... that it will present at two,upcoming investor conferences. Russell ... Rodman and Renshaw 9th Annual Healthcare Conference Monday, ... 18th Annual Healthcare Conference Tuesday, November 6, 8:00 ...
... CAMBRIDGE, Mass., Oct. 25 Millennium,Pharmaceuticals, Inc. (Nasdaq: ... of a,conference call at 8:00 a.m. ET on ... Company,s third-quarter 2007 financial and,operational results and upcoming ... be available on the webcast. Prior to the,conference ...
... Submission Seeks Approval of Genasense in Relapsed/Refractory Patients, ... (Nasdaq: GNTA ) announced that the Company ... to Dr. Janet Woodcock, Acting,Director of the Center ... and Drug Administration (FDA). The appeal asks that ...
Other Biology Technology:Millennium to Webcast Third-Quarter 2007 Financial and Operational Results 2Genta Completes Appeal of FDA Decision for Genasense(R) in CLL 2Genta Completes Appeal of FDA Decision for Genasense(R) in CLL 3Genta Completes Appeal of FDA Decision for Genasense(R) in CLL 4Genta Completes Appeal of FDA Decision for Genasense(R) in CLL 5